Founder & CEO
Coharts
Coharts provides a platform that helps life‑science organizations extract actionable insights from complex biological data, enabling deeper understanding of disease mechanisms and therapeutic targets. By integrating advanced analytics and machine‑learning tools, the service streamlines research workflows and accelerates hypothesis generation for drug discovery teams.
- Artificial Intelligence
- Data & Analytics
- Biotechnology
Updated 4 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Problem
Life‑science researchers often struggle to extract meaningful conclusions from large, heterogeneous biological datasets, leading to slow target identification and prolonged drug discovery timelines.
Solution
Coharts offers a cloud‑based platform that integrates multi‑omics data—such as genomics, transcriptomics, proteomics, and metabolomics—into unified disease models. The platform applies statistical and machine‑learning methods to map molecular interactions and infer disease mechanisms. By presenting these insights through interactive visualizations and actionable reports, scientists can prioritize targets and design experiments with greater confidence. The solution streamlines data handling, reduces manual analysis effort, and accelerates decision‑making across the drug development pipeline.
Target Audience
Primary users are pharmaceutical and biotech research teams, as well as academic laboratories focused on target discovery and mechanistic studies.
Features
- Automated ingestion and harmonization of diverse omics datasets from public repositories and internal sources
- Integrated network analysis and pathway enrichment tools to reveal mechanistic links between molecular entities
- Machine‑learning models that predict disease relevance of genes, proteins, and metabolites
- Interactive dashboards with customizable visualizations of multi‑layered biological networks
- Exportable reports and API endpoints for seamless integration with downstream bioinformatics workflows